Ars Pharmaceuticals Inc (SPRY)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 859 |
| % of all portfolios: | 0.005% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
0 |
$0 |
| Sells |
0 |
$0 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 27 Mar 2024 |
RA CAPITAL MANAGEMENT, L.P. |
Director , 10% |
27 Mar 2024 |
505,954 |
9.79 |
4,953,290 |
| 27 Mar 2024 |
RA CAPITAL MANAGEMENT, L.P. |
Director , 10% |
26 Mar 2024 |
457,745 |
9.55 |
4,371,465 |
| 27 Mar 2024 |
RA CAPITAL MANAGEMENT, L.P. |
Director , 10% |
25 Mar 2024 |
437,600 |
9.06 |
3,964,656 |
| 02 Oct 2023 |
FITZPATRICK ALEXANDER A |
Chief Legal Officer |
29 Sep 2023 |
46,258 |
3.78 |
174,994 |
| 02 Oct 2023 |
FITZPATRICK ALEXANDER A |
Chief Legal Officer |
28 Sep 2023 |
40,000 |
3.62 |
144,960 |
| 25 Sep 2023 |
RA CAPITAL MANAGEMENT, L.P. |
Director |
21 Sep 2023 |
2,508,691 |
2.97 |
7,450,812 |
| 25 Sep 2023 |
RA CAPITAL MANAGEMENT, L.P. |
Director |
21 Sep 2023 |
191,309 |
3.83 |
732,713 |
| 31 Aug 2023 |
RA CAPITAL MANAGEMENT, L.P. |
Director |
29 Aug 2023 |
3,750,000 |
6.20 |
23,250,000 |
| 31 Aug 2023 |
ORBIMED ADVISORS LLC |
Director |
29 Aug 2023 |
500,000 |
6.20 |
3,100,000 |
| 01 Dec 2022 |
SCOTT KATHLEEN D. |
Chief Financial Officer |
29 Nov 2022 |
8,250 |
6.24 |
51,506 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock